99-30728. Agency Information Collection Activities: Proposed Collection; Comment Request; FDA Safety Alert/Public Health Advisory Readership Survey  

  • [Federal Register Volume 64, Number 227 (Friday, November 26, 1999)]
    [Notices]
    [Pages 66479-66480]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-30728]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 99N-4933]
    
    
    Agency Information Collection Activities: Proposed Collection; 
    Comment Request; FDA Safety Alert/Public Health Advisory Readership 
    Survey
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing an 
    opportunity for public comment on the proposed collection of certain 
    information by the agency. Under the Paperwork Reduction Act of 1995 
    (the PRA), Federal agencies are required to publish notice in the 
    Federal Register concerning each proposed collection of information, 
    including each proposed extension of an existing information 
    collection, and to allow 60 days for public comment in response to the 
    notice. This notice solicits comments on information collection 
    requirements for FDA Safety Alert/Public Health Advisory Readership 
    Survey.
    
    DATES: Submit written comments on the collection of information by 
    January 25, 2000.
    
    ADDRESSES: Submit written comments on the collection of information to 
    the Dockets Management Branch (HFA-305), Food and Drug Administration, 
    5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should 
    be identified with the docket number found in brackets in the heading 
    of this document.
    
    FOR FURTHER INFORMATION CONTACT: Peggy Schlosburg, Office of 
    Information Resources Management (HFA-250), Food and Drug 
    Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1223.
    
    SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520) Federal 
    agencies must obtain approval from the Office of Management and Budget 
    (OMB) for each collection of information they conduct or sponsor. 
    ``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 
    1320.3(c) and includes agency requests or requirements that members of 
    the public submit reports, keep records, or provide information to a 
    third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) 
    requires Federal agencies to provide a 60-day notice in the Federal 
    Register concerning each proposed collection of information, including 
    each proposed extension of an existing collection of information, 
    before submitting the collection to OMB for approval. To comply with 
    this
    
    [[Page 66480]]
    
    requirement, FDA is publishing notice of the proposed collection of 
    information set forth in this document.
         With respect to the following collection of information, FDA 
    invites comments on: (1) Whether the proposed collection of information 
    is necessary for the proper performance of FDA's functions, including 
    whether the information will have practical utility; (2) the accuracy 
    of FDA's estimate of the burden of the proposed collection of 
    information, including the validity of the methodology and assumptions 
    used; (3) ways to enhance the quality, utility, and clarity of the 
    information to be collected; and (4) ways to minimize the burden of the 
    collection of information on respondents, including through the use of 
    automated collection techniques, when appropriate, and other forms of 
    information technology.
    
     FDA Safety Alert/Public Health Advisory Readership Survey (OMB No. 
    0910-0341B--Extension)
    
         Section 705(b) of the Federal Food, Drug, and Cosmetic Act (the 
    act) (21 U.S.C. 375(b)) authorizes FDA to disseminate information 
    concerning imminent danger to public health by any regulated product. 
    The Center for Devices and Radiological Health (CDRH) communicates 
    these risks to user communities through two publications: (1) The FDA 
    Safety Alert and (2) the Public Health Advisory. Safety alerts and 
    advisories are sent to organizations such as hospitals, nursing homes, 
    hospices, home health care agencies, manufacturers, retail pharmacies, 
    and other health care providers. Subjects of previous alerts included 
    spontaneous combustion risks in large quantities of patient examination 
    gloves, hazards associated with the use of electric heating pads, and 
    retinal photic injuries from operating microscopes during cataract 
    surgery.
         Section 1701(a)(4) of the Public Health Service Act (42 U.S.C. 
    300u(a)(4)) authorizes FDA to conduct research relating to health 
    information. FDA seeks to evaluate the clarity, timeliness, and impact 
    of safety alerts and public health advisories by surveying a sample of 
    recipients. Subjects will receive a questionnaire to be completed and 
    returned to FDA. The information to be collected will address how 
    clearly actions for reducing risk are explained, the timeliness of the 
    information, and whether the reader has taken any action to eliminate 
    or reduce risk as a result of information in the alert. Subjects will 
    also be asked whether they wish to receive future alerts 
    electronically, as well as how the safety alert program might be 
    improved.
         The information collected will be used to shape FDA's editorial 
    policy for the safety alerts and public health advisories. 
    Understanding how target audiences view these publications will aid in 
    deciding what changes should be considered in their content, format, 
    and method of dissemination.
         FDA estimates the burden of this collection of information as 
    follows:
    
                  Table 1.--Estimated Annual Reporting Burden1
    ------------------------------------------------------------------------
                          Annual
         No. of        Frequency per   Total Annual    Hours per     Total
       Respondents       Response       Responses      Response      Hours
    ------------------------------------------------------------------------
    308               3               924            1.7           157
    ------------------------------------------------------------------------
    \1\ There are no capital costs or operating and maintenance costs
      associated with this collection of information.
    
         Based on the history of the safety alert and public health 
    advisory program, it is estimated that an average of three collections 
    will be conducted a year. The total burden of response time is 
    estimated at 10 minutes per survey. This was derived by CDRH staff 
    completing the survey and through discussions with the contacts in 
    trade organizations.
    
        Dated: November 19, 1999.
    William K. Hubbard,
    Senior Associate Commissioner for Policy, Planning, and Legislation.
    [FR Doc. 99-30728 Filed 11-24-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
11/26/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-30728
Dates:
Submit written comments on the collection of information by January 25, 2000.
Pages:
66479-66480 (2 pages)
Docket Numbers:
Docket No. 99N-4933
PDF File:
99-30728.pdf